Barclays将Kodiak Sciences Inc.的股票评级从低配调升至等权重,同时将目标价从7美元大幅上调至17美元。
Barclays将Kodiak Sciences Inc.的股票评级从低配调升至等权重,同时将目标价从7美元大幅上调至17美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.